6929.HK
OrbusNeich Medical Group Holdings Limited

Healthcare · Medical Instruments & Supplies · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

474.47M USD

Market Cap

395.68M USD

Margin of Safety

16.6%

Intrinsic / Market Ratio

1.20×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

557.61M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

451.19M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

414.61M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

474.47M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

474.47M USD

from the sum above

Market Cap

395.68M USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

1.20×

the ratio the screener ranks by; Margin of Safety +16.6% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 557.61M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)337.10M USD
+②Net Cash Today215.01M USD
+③Growth Value5.51M USD
=Value557.61M USD

EPV of the Operations (NOPAT over WACC)

337.10M USD

Net cash today

+215.01M USD

Growth Value

+5.51M USD

Value

557.61M USD

①EPV (earnings power value)

337.10M USD

②Net Cash Today

215.01M USD

③Growth Value

5.51M USD

Market value

Market Cap395.68M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+29.0%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 451.19M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE272.79M USD
+②Equity at Year 15, Today178.40M USD
=Value451.19M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

272.79M USD

②Equity at Year 15, Today

178.40M USD

Market value

Market Cap395.68M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+12.3%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 414.61M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (a change in working capital above half the operating profit in the latest three years), so the value is the book value today, 414.61M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap395.68M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+4.6%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 10.43%
Cost of Equity =Risk-Free Rate 4.50%+Beta (default) 1.00×Market Risk Premium 6.00%= 10.50%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 5.06M USDPretax Income 47.13M USD= 10.73%

The tax the interest saves.

Interest Expense =EBIT 47.30M USD−Pretax Income 47.13M USD= 168.17K USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 168.17K USDTotal Debt 3.92M USD×(1 − Tax Rate for WACC 10.73%)= 3.83%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 3.92M USDMarket Cap + Total Debt 395.68M USD + 3.92M USD= 0.98%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 99.02%×Cost of Equity 10.50%+Debt Weight 0.98%×Cost of Debt 3.83%= 10.43%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2025-12-31.

Total Assets 453.36M USD − Total Liabilities 38.75M USD = Book Value Today 414.61M USD

Total Debt 3.92M USD − Cash and Short-Term Investments 218.92M USD = Net Debt Today -215.01M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-0.5%at most 5%passes823,252,837 / 827,022,837
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets-4.9%at least -10.0%passes(19.55M USD − 41.94M USD) ÷ 453.36M USD
Price to bookMarket Cap ÷ Book Value Today0.95×at most 3×passes395.68M USD ÷ 414.61M USD
Operating marginOperating Income ÷ Revenue22.1%above 10.0%passes39.99M USD ÷ 180.63M USD
Revenue growthRevenue ÷ Revenue a Year Before − 110.0%above 10.0%does not pass180.63M USD / 164.26M USD
Net cash(Cash − Total Debt) ÷ Market Cap54.3%above -30%passes(218.92M USD − 3.92M USD) ÷ 395.68M USD
Operating efficiencyOperating Income ÷ Gross Profit32.6%above 25.0%passes39.99M USD ÷ 122.55M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

3.77 HKD

Enterprise value

2.87B HKD

the provider's own figure

EV / EBITDA

58.33×

Price / book

0.94×

the provider's book

Price / earnings

9.18×

Return on equity

10.6%

the provider's figure, not this page's

Profit margin

22.3%

Revenue growth

18.1%

Analyst target, mean

5.66 HKD

Analysts

2

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

136.96M154.02M164.26M180.63M

Gross profit

92.55M106.60M114.58M122.55M

Operating income

24.16M39.44M35.19M39.99M

EBITDA

operating income before depreciation and amortisation

27.16M54.02M47.97M53.52M

Pretax income

21.81M49.68M42.45M47.13M

Net income

18.51M45.12M39.76M41.94M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

20.30M44.32M43.44M42.88M

R&D

14.13M14.39M17.06M15.75M
Balance sheet, year end

Total assets

351.41M410.55M431.44M453.36M

Total liabilities

28.52M40.77M36.67M38.75M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

322.89M368.77M393.70M413.47M

Total debt

4.03M7.47M4.21M3.92M

Cash and equivalents

229.38M256.03M248.84M218.92M

Net PP&E

fixed assets after depreciation

13.31M17.14M26.08M44.65M

Working capital

current assets less current liabilities

290.75M312.65M331.06M317.71M
Cash flow

Operating cash flow

23.45M23.06M13.13M19.55M

Capital expenditure

paid out, so below zero

-3.34M-7.49M-11.28M-18.40M

Depreciation and amortisation

3.89M4.21M5.31M6.22M

Free cash flow

operating cash flow plus capital expenditure

20.12M15.57M1.84M1.15M